Clinical trials
Observational Non-alcoholic Fatty Liver Disease trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 4 |
| Completed | 3 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| IMDEA Food | 2 |
| Consorci Sanitari de l'Alt Penedès i Garraf | 1 |
| Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 1 |
| Fundación Marques de Valdecilla | 1 |
| Hospital General Universitario Gregorio Marañon | 1 |
| Hospital Universitari Vall d'Hebron Research Institute | 1 |
| Institut Investigacio Sanitaria Pere Virgili | 1 |
| Newcastle University | 1 |
| PharmaNest, Inc | 1 |
| Target PharmaSolutions, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 12 |
| Liver Diseases | 6 |
| Liver Cirrhosis | 4 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Fatty Liver | 2 |
| Obesity | 2 |
| Pediatric Obesity | 2 |
| Carcinoma, Hepatocellular | 1 |
| Cerebrovascular Disorders | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.